These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 6136983)

  • 1. Betamimetic activity of peptide catecholamine conjugates.
    Rosenkranz RP; Jacobson KA; Verlander MS; Goodman M; Melmon KL
    Proc West Pharmacol Soc; 1983; 26():381-5. PubMed ID: 6136983
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo betamimetic activity of congeners of isoproterenol.
    Rosenkranz RP; Jacobson KA; Goodman M; Verlander M; Melmon KL
    Proc West Pharmacol Soc; 1982; 25():19-23. PubMed ID: 6126881
    [No Abstract]   [Full Text] [Related]  

  • 3. Conjugates of catecholamines. IV. In vitro and in vivo pharmacological activity of monodisperse oligopeptide conjugates.
    Rosenkranz RP; Jacobson KA; Verlander MS; Klevans L; O'Donnell M; Goodman M; Melmon KL
    J Pharmacol Exp Ther; 1983 Nov; 227(2):267-73. PubMed ID: 6138424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugates of catecholamines. II. In vitro and in vivo pharmacological activity of N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol.
    Rosenkranz RP; Hoffman BB; Jacobson KA; Verlander MS; Klevans L; O'Donnell M; Goodman M; Melmon KL
    Mol Pharmacol; 1983 Nov; 24(3):429-35. PubMed ID: 6138706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugates of catecholamines. VII. Synthesis and beta-adrenergic activity of peptide catecholamine conjugates.
    Fukuda M; Beechan CM; Verlander M; Goodman M; Khan MM; Melmon KL
    Int J Pept Protein Res; 1987 Mar; 29(3):300-17. PubMed ID: 2885293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some novel approaches to the design and synthesis of peptide-catecholamine conjugates.
    Verlander MS; Jacobson KA; Rosenkranz RP; Melmon KL; Goodman M
    Biopolymers; 1983 Jan; 22(1):531-45. PubMed ID: 6324920
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation of changes in the permeability of the blood-brain barrier from catecholamine-induced changes in blood pressure of normotensive and spontaneously hypertensive rats.
    Sankar R; Domer FR; Taylor B
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):343-54. PubMed ID: 7178648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats.
    Chang HY; Klein RM; Kunos G
    J Pharmacol Exp Ther; 1982 Jun; 221(3):784-9. PubMed ID: 6283064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugates of catecholamines. III. Synthesis and characterization of monodisperse oligopeptides conjugates related to isoproterenol.
    Jacobson KA; Verlander MS; Rosenkranz RP; Melmon KL; Goodman M
    Int J Pept Protein Res; 1983 Sep; 22(3):284-304. PubMed ID: 6629645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of the stereoisomers of dobutamine.
    Ruffolo RR; Yaden EL
    J Pharmacol Exp Ther; 1983 Jan; 224(1):46-50. PubMed ID: 6294282
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of alpha and beta blocker properties of parahydroxybenzonitrile on the cardiovascular system of rats].
    Cheav SL; Kirkiacharian S; Piéri F; Poisson D
    Ann Pharm Fr; 1998; 56(5):205-8. PubMed ID: 9805819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
    Ruffolo RR; Spradlin TA; Pollock GD; Waddell JE; Murphy PJ
    J Pharmacol Exp Ther; 1981 Nov; 219(2):447-52. PubMed ID: 6270308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered beta-receptor responsiveness in uraemic rats.
    Mann JF; Hausen M; Kutter A; Sudhoff R; Ritz E
    Proc Eur Dial Transplant Assoc; 1983; 19():788-9. PubMed ID: 6308604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta1 adrenergic receptor-mediated enhancement of hippocampal CA3 network activity.
    Jurgens CW; Rau KE; Knudson CA; King JD; Carr PA; Porter JE; Doze VA
    J Pharmacol Exp Ther; 2005 Aug; 314(2):552-60. PubMed ID: 15908512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of the trimmed rat subcutaneous adipose tissue beta-receptors to catecholamines in ontogenesis.
    Mühlbachová E; Mourek J
    Physiol Bohemoslov; 1982; 31(1):29-36. PubMed ID: 6280222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of monoterpene derivative KP-19 on the pressor activity of catecholamines in rats.
    Librowski T; Czarnecki R; Jastrzebska M; Sapa J
    Pol J Pharmacol; 2000; 52(2):101-5. PubMed ID: 10949111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
    Höcht C; Opezzo JA; Gironacci MM; Peña C; Taira CA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):30-4. PubMed ID: 15730431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism.
    Haskó G; Shanley TP; Egnaczyk G; Németh ZH; Salzman AL; Vizi ES; Szabó C
    Br J Pharmacol; 1998 Nov; 125(6):1297-303. PubMed ID: 9863660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.